Lab Notes: FMC enters into a $200M bio-acquisition; Virpax going the OTC route again
July 08, 2022 at 16:14 PM EDT
Virpax is once again taking the OTC route for a new product candidate.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |